(Q33922669)

30 July 2017

1 reference

title

Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease (English)

1 reference

30 July 2017

0 references

de la Monte SM

1

1 reference

30 July 2017

Sohn YK

2

1 reference

30 July 2017

Etienne D

3

1 reference

30 July 2017

Kraft J

4

1 reference

30 July 2017

Wands JR

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Annals of the New York Academy of Sciences

30 July 2017

published in

1 reference

30 July 2017

volume

903

1 reference

30 July 2017

page(s)

61-71

1 reference

Impaired brain microcirculation may trigger Alzheimer's disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Why are stroke patients prone to develop dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Multicenter clinicopathological correlation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Redox signaling: nitrosylation and related target interactions of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Dorsal root ganglion neurons of embryonic chicks contain nitric oxide synthase and respond to nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06351.X

10.1111/J.1749-6632.2000.TB06351.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference